SCHEMBL2294073

SCHEMBL2294073

O=C1CC=CCCCCCCCCCCC1

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TRIM24 O15164 2/20 0.48
TRIM33 Q9UPN9 2/20 0.48
ALDH1A1 P00352 2/20 0.48
CXCR3 P49682 1/20 0.36
HDAC3 O15379 1/20 0.32
HDAC4 P56524 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC7 Q8WUI4 1/20 0.32
HDAC2 Q92769 1/20 0.32
HDAC10 Q969S8 1/20 0.32
HDAC11 Q96DB2 1/20 0.32
HDAC8 Q9BY41 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
HDAC9 Q9UKV0 1/20 0.32
HDAC5 Q9UQL6 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28991492 1.00 TRIM24 (0.48) TRIM24TRIM33ALDH1A1CXCR3HDAC3
SCHEMBL12513193 1.00 TRIM24 (0.48) TRIM24TRIM33ALDH1A1CXCR3HDAC3
SCHEMBL8847356 1.00 TRIM24 (0.48) TRIM24TRIM33ALDH1A1CXCR3HDAC3
SCHEMBL4071900 1.00 TRIM24 (0.48) TRIM24TRIM33ALDH1A1CXCR3HDAC3
SCHEMBL6904016 1.00 TRIM24 (0.48) TRIM24TRIM33ALDH1A1CXCR3HDAC3
SCHEMBL1539238 1.00 TRIM24 (0.48) TRIM24TRIM33ALDH1A1CXCR3HDAC3
SCHEMBL5177610 1.00 TRIM24 (0.48) TRIM24TRIM33ALDH1A1CXCR3HDAC3
SCHEMBL3421758 1.00 TRIM24 (0.48) TRIM24TRIM33ALDH1A1CXCR3HDAC3
SCHEMBL7532053 1.00 TRIM24 (0.48) TRIM24TRIM33ALDH1A1CXCR3HDAC3
SCHEMBL869651 1.00 TRIM24 (0.48) TRIM24TRIM33ALDH1A1CXCR3HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 234 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250188501-A1 SEMISYNTHETIC ROUTES TO ORGANIC COMPOUNDS AGAIN BIO APS (DK) 2025-06-12 US claimed
US-10844036-B2 Processes for obtaining purified unsaturated macrocyclic compounds AGAN AROMA & FINE CHEMICALS LTD. (IL) 2020-11-24 US claimed
US-20190345128-A1 PROCESSES FOR OBTAINING PURIFIED UNSATURATED MACROCYCLIC COMPOUNDS AGAN AROMA & FINE CHEMICALS LTD. (IL) 2019-11-14 US claimed
EP-3548455-A1 PROCESSES FOR OBTAINING PURIFIED UNSATURATED MACROCYCLIC COMPOUNDS Agan Aroma&fine Chemicals Ltd. (IL) 2019-10-09 EP claimed
EP-3359517-B1 METHOD FOR THE PURIFICATION OF CYCLOHEXADEC-8-EN-1-ON BASF SE (DE) 2019-09-25 EP claimed
US-20180312458-A1 METHOD F0R THE PURIFICATION OF CYCLOHEXADEC-8-EN-1-ONE BASF SE (DE) 2018-11-01 US claimed
WO-2018104856-A1 PROCESSES FOR OBTAINING PURIFIED UNSATURATED MACROCYCLIC COMPOUNDS AGAN AROMA & FINE CHEMICALS LTD. (IL) 2018-06-14 WO claimed
WO-2017060437-A1 METHOD FOR THE PURIFICATION OF CYCLOHEXADEC-8-EN-1-ONE BASF SE (DE) 2017-04-13 WO claimed
EP-3153493-A1 METHOD FOR THE PURIFICATION OF CYCLOHEXADEC-8-EN-1-ON BASF SE (DE) 2017-04-12 EP claimed
US-20150057207-A1 NOVEL ORGANOLEPTIC COMPOUNDS INTERNATIONAL FLAVORS & FRAGRANCES INC. 2015-02-26 US claimed
CN-122028974-A Ribonucleic acid-based microcapsules 弗门尼舍有限公司 2026-05-12 CN disclosed
US-12616948-B2 Polyamide microcapsules FIRMENICH SA (CH) 2026-05-05 US disclosed
WO-2026087780-A1 CORE-SHELL MICROCAPSULES FIRMENICH SA (CH) 2026-04-30 WO disclosed
EP-4090453-B1 MICROCAPSULES COATED WITH A POLYSUCCINIMIDE DERIVATIVE FIRMENICH & CIE (CH) 2026-04-29 EP disclosed
EP-4713129-A1 ORGANOSILICON-BASED MICROCAPSULES Firmenich SA (CH) 2026-03-25 EP disclosed
EP-1440963-A1 Production method of ketone compound Japan Energy Corporation (JP) 2004-07-28 EP disclosed
US-5936100-A METAL CARBENE COMPLEXES OF RUTHENIUM OR OSMIUM STUDIENGESELLSCHAFT KOHLE MBH (DE) 1999-08-10 US disclosed
EP-0584477-B1 Use of a cyclopentadecenone as a perfuming ingredient FIRMENICH & CIE (CH) 1997-09-24 EP disclosed
US-5354735-A 3-Methylcyclopentadec-5-en-1-one having a nitro-musk type odor; detergents; perfumes; hair products; cosmetics FIRMENICH SA (CH) 1994-10-11 US disclosed
EP-0584477-A1 Use of a cyclopentadecenone as a perfuming ingredient FIRMENICH SA (CH) 1994-03-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180312458-A1 METHOD F0R THE PURIFICATION OF CYCLOHEXADEC-8-EN-1-ONE CNR1, C1R, FFAR1 TRIM24 3973/4885TRIM33 3935/4885ALDH1A1 289/4885
US-20150057207-A1 NOVEL ORGANOLEPTIC COMPOUNDS TRPA1, TRPV1, TRPV5 TRIM24 3258/4885TRIM33 3287/4885ALDH1A1 353/4885
US-12616948-B2 Polyamide microcapsules HDHD5, DDC, USP39 TRIM24 3619/4885TRIM33 3754/4885ALDH1A1 4007/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.